A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma

A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma

Abstract Objective To improve prediction, the AJCC staging system was revised to be consistent with upfront surgery (UFS) and neoadjuvant therapy (NAT) for PDAC. Background The AJCC staging system was designed for patients who have had UFS for PDAC, and it has limited predictive power for patients r...

Full description

Bibliographic Details
Main Authors: Lingyu Zhu, Shuo Shen, Huan Wang, Guoxiao Zhang, Xiaoyi Yin, Xiaohan Shi, Suizhi Gao, Jiawei Han, Yiwei Ren, Jian Wang, Hui Jiang, Shiwei Guo, Gang Jin
Format: Article
Language:English
Published: BMC 2023-08-01
Series:BMC Cancer
Subjects:
Neoadjuvant therapy
Upfront surgery
Staging
Prognosis
Survival
Grade
Online Access:https://doi.org/10.1186/s12885-023-11181-x

Internet

https://doi.org/10.1186/s12885-023-11181-x

Similar Items